Tesamorelin
Quantity
-
DetailTesamorelin 10 mg – GHRH analog for visceral fat reduction๐งช What is Tesamorelin?Tesamorelin is a modified version of natural GHRH, designed to increase the release of endogenous growth hormone from the pituitary gland. Due to its improved stability and biological activity, it has a pronounced lipolytic effect, especially in people with high levels of abdominal fat.โ๏ธ Stimulates growth hormone (GH)โ๏ธ Improves body compositionโ๏ธ Has a potential anti-aging effectโ๏ธ Supports IGF-1 synthesisBuy Tesamorelin 10 mg online at a great price in Romania, directly from Peptology.โ๏ธ How does Tesamorelin work?Tesamorelin acts as a GHRH analog, activating the pituitary gland to secrete higher levels of GH. This results in:Accelerated lipolysis and reduction of visceral fatIncreased IGF-1 levels, linked to cell growth and repairImproved muscle ratio and metabolic profileCognitive and neuroprotective effects (in studies)๐ Clinical studiesPhase Purpose ResultsI Safety and tolerability Good tolerance, minimal side effectsII. Fat Reduction Effectiveness Significant reduction in abdominal fatIII Long-term safety and efficacy Confirmed effect on visceral fat, increased IGF-1, reduced triglyceride profile๐ Benefits of Tesamorelin 10 mgโ๏ธ Visceral fat reductionโ๏ธ Increase IGF-1 naturallyโ๏ธ Improve body composition and muscle massโ๏ธ Potential cognitive benefits in elderly patientsโ๏ธ Convenient subcutaneous applicationโ๏ธ Suitable for anti-aging protocolsIdeal for research protocols focused on visceral fat reduction, body composition optimization and anti-aging effects.โ ๏ธ Possible side effectsAs with all peptides, mild to moderate side effects may occur when taking Tesamorelin:Injection site irritationMild peripheral edema (water retention)Joint or muscle painHeadache or feeling of "tightness"In rare cases - increased blood sugar levelsMost side effects are temporary and resolve with dose adaptation or adjustment.โ Why choose Tesamorelin from PEPTIDESHEALTHS?Strongly proven effect - up to 16% reduction in visceral fat in phases II-III of the randomized clinical trial (RCT).Improved metabolic markers and stable IGF-1 profile without serious hepatotoxic effects.Clear protocol - daily subcutaneous dose, convenient for long-term therapies.The product is intended for research purposes only!
-
Customer ReviewsNo comments